EFFECT OF EXOGENOUS MIDDLE MOLECULAR-WEIGHT NEUROFILAMENT AND ITS NUCLEAR TRANSLOCATION ON CELL APOPTOSIS

honglian li,jianying shen

DOI: https://doi.org/10.1016/j.jalz.2014.05.726

2014-01-01

Alzheimer s & Dementia

Abstract:Neurofibrillary tangle (NFT) is detected in Alzheimer Disease (AD) and many other human neurodegenerative disorders. NFT is composed of hyperphosphorylated microtubule associated protein tau, neurofilaments (NFs) and other cytoskeleton proteins. Many studies demonstrated that tau had an anti-apoptosis effect, and the accumulation of dephosphorylated tau in neuronal nucleus had the capacity to interact with DNA and protect DNA from damage. However the possible effect of NFs on cell survival remains unclear. To explore the possible effect of exogenous NF and its localization in cell on cell apoptosis, middle molecular weight neurofilament (NFM) plasmid and the longest form of human tau (tau441) plasmid (EGFP-C1-NFM, EGFP-C1-tau, HA-C1-NFM, HA-tau) were respectively transfected into mouse neuroblastma (N2a) cells. After transfection for 36 hours, cells were treated with Staurosporine (STP, a broad spectrum apoptosis agent) for 3 h, 6 h, 12 h, and 24 h. Detected with flow cytometry, the apoptosis rates of all groups transfected with tau plasmid were much lower than groups transfected with empty plasmid (3 h, p<0.05, 6 h-24 h, p<0.01). But there were no significant differences between the apoptosis rates of NFM-transfection groups and the empty plasmid groups, which indicated that exogenous NFM had no anti-apoptosis effect. Checking the two protein's localization in cells by immunofluorescence, we observed that endogenous tau was low expressed in cytoplasm, and exogenous tau was expressed both in cytoplasm and nucleus; endogenous NFM was extremely low expressed, almost invisible, and exogenous NFM mainly located in the cytoplasm of N2a cell. The cytoplasmic and nuclear protein was further separated for western blot to detect the levels of two exogenous proteins in different parts of cells. Results showed: the expression of endogenous tau was very low, while exogenous tau was expressed both in cytoplasm and nucleus. Contrary with tau, exogenous NFM was not expressed in nucleus. To investigate whether the no anti-apoptosis effect of NFM completely or partly was due to its cytoplasm position, NFM plasmid was recombined with nuclear location signal (NLS) to get EGFP-C1-NLS-NFM and HA-C1-NLS-NFM and corresponding empty plasmids. Immunofluorescence showed parts of NFM recombined with NLS translocated from cytoplasm into nucleus. And after STP treatment, immunofluorescence showed that most cells transfected with NFM plasmid recombined with NLS were cleaved caspase-3 (marker of apoptosis) negative, while most cells transfected with EGFP-C1-NFM were cleaved caspase-3 positive. This demonstrated that exogenous NFM translocated from cytoplasm into nucleus could protect cells against apoptosis induced by STP. Our results showed that normal NFM didn't inhibit apoptosis may be based on its no-translocated into the nucleus, and the mechanism underlying the anti-apoptosis function of NFM after translocation into cell nuclei needs further research. This result also provides a new sight to research the effect of cytoskeleton proteins on cell survival in human neurodegenerative disorders.